選択的プロゲステロン受容体修飾薬
参考資料

1 2 3  “Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis”. Endocrine Reviews 26 (3):  423–38. (May 2005). doi:10.1210/er.2005-0001. PMID 15857972.
↑  “The nuclear receptor superfamily: the second decade”. Cell 83 (6):  835–9. (Dec 1995). doi:10.1016/0092-8674(95)90199-X. PMC 6159888. PMID 8521507. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159888/.
1 2  “The A and B forms of the chicken progesterone receptor arise by alternate initiation of translation of a unique mRNA”. Biochemical and Biophysical Research Communications 149 (2):  493–501. (Dec 1987). doi:10.1016/0006-291X(87)90395-0. PMID 3426587.
1 2  “Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B”. The EMBO Journal 9 (5):  1603–14. (May 1990). doi:10.1002/j.1460-2075.1990.tb08280.x. PMC 551856. PMID 2328727. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC551856/.
↑  “Novel isoforms of the mRNA for human female sex steroid hormone receptors”. The Journal of Steroid Biochemistry and Molecular Biology 83 (1–5):  25–30. (Dec 2002). doi:10.1016/S0960-0760(02)00255-8. PMID 12650698.
↑  “Isoform/variant mRNAs for sex steroid hormone receptors in humans”. Trends in Endocrinology and Metabolism 14 (3):  124–9. (Apr 2003). doi:10.1016/S1043-2760(03)00028-6. PMID 12670738.
1 2 3 4  “Progesterone receptors: form and function in brain”. Frontiers in Neuroendocrinology 29 (2):  313–39. (May 2008). doi:10.1016/j.yfrne.2008.02.001. PMC 2398769. PMID 18374402. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2398769/.
1 2 3 4  “Estrogen and progesterone receptors: from molecular structures to clinical targets”. Cellular and Molecular Life Sciences 66 (15):  2405–26. (Aug 2009). doi:10.1007/s00018-009-0017-3. PMID 19333551.
1 2 3 4 5 6  “Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications”. Human Reproduction Update 11 (3):  293–307. (2005). doi:10.1093/humupd/dmi002. PMID 15790602.
1 2 3 4 5 6 7 8 9 10 11 12  “A new generation of progesterone receptor modulators”. Steroids 73 (7):  689–701. (Aug 2008). doi:10.1016/j.steroids.2008.03.005. PMID 18472121.
1 2  “Progesterone receptor and the mechanism of action of progesterone antagonists”. The Journal of Steroid Biochemistry and Molecular Biology 53 (1–6):  449–58. (Jun 1995). doi:10.1016/0960-0760(95)00091-d. PMID 7626494.
1 2 3 4  “X-ray structures of progesterone receptor ligand binding domain in its agonist state reveal differing mechanisms for mixed profiles of 11β-substituted steroids”. The Journal of Biological Chemistry 287 (24):  20333–43. (Jun 2012). doi:10.1074/jbc.M111.308403. PMC 3370215. PMID 22535964. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3370215/.
↑  “The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT”. Molecular Endocrinology 11 (6):  693–705. (Jun 1997). doi:10.1210/me.11.6.693. PMID 9171233.
↑  “Coregulator function: a key to understanding tissue specificity of selective receptor modulators”. Endocrine Reviews 25 (1):  45–71. (Feb 2004). doi:10.1210/er.2003-0023. PMID 14769827.
↑  “Evidence that heat shock protein-70 associated with progesterone receptors is not involved in receptor-DNA binding”. Molecular Endocrinology 5 (12):  1993–2004. (Dec 1991). doi:10.1210/mend-5-12-1993. PMID 1791844.
↑  “Assembly of progesterone receptor with heat shock proteins and receptor activation are ATP mediated events”. The Journal of Biological Chemistry 267 (2):  1350–6. (Jan 1992). doi:10.1016/S0021-9258(18)48438-4. PMID 1730655.
↑  “Dimerization of mammalian progesterone receptors occurs in the absence of DNA and is related to the release of the 90-kDa heat shock protein”. Proceedings of the National Academy of Sciences of the United States of America 88 (1):  72–6. (Jan 1991). Bibcode: 1991PNAS...88...72D. doi:10.1073/pnas.88.1.72. PMC 50750. PMID 1986383. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC50750/.
↑  “Mechanisms of nuclear localization of the progesterone receptor: evidence for interaction between monomers”. Cell 57 (7):  1147–54. (Jun 1989). doi:10.1016/0092-8674(89)90052-4. PMID 2736623.
↑  “Molecular pathways of steroid receptor action”. Biology of Reproduction 46 (2):  163–7. (Feb 1992). doi:10.1095/biolreprod46.2.163. PMID 1536890.
↑  “Analysis of the mechanism of steroid hormone receptor-dependent gene activation in cell-free systems”. Endocrine Reviews 13 (3):  525–35. (Aug 1992). doi:10.1210/edrv-13-3-525. PMID 1425487.
↑  “Combinatorial control of gene expression by nuclear receptors and coregulators”. Cell 108 (4):  465–74. (Feb 2002). doi:10.1016/S0092-8674(02)00641-4. PMID 11909518.
↑  “Sequence and characterization of a coactivator for the steroid hormone receptor superfamily”. Science 270 (5240):  1354–7. (Nov 1995). Bibcode: 1995Sci...270.1354O. doi:10.1126/science.270.5240.1354. PMID 7481822.
↑  “The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor”. Molecular and Cellular Biology 18 (3):  1369–78. (Mar 1998). doi:10.1128/mcb.18.3.1369. PMC 108850. PMID 9488452. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC108850/.
↑  “Coactivator/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486”. Proceedings of the National Academy of Sciences of the United States of America 99 (12):  7940–4. (Jun 2002). Bibcode: 2002PNAS...99.7940L. doi:10.1073/pnas.122225699. PMC 122999. PMID 12048256. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC122999/.
1 2 3 4  “Synthesis and biological evaluation of partially fluorinated antiprogestins and mesoprogestins”. Steroids 78 (2):  255–67. (Feb 2013). doi:10.1016/j.steroids.2012.09.010. PMID 23178161.
1 2 3 4 5 6  “Synthesis and biological evaluation of 11' imidazolyl antiprogestins and mesoprogestins”. Steroids 92:  45–55. (Dec 2014). doi:10.1016/j.steroids.2014.08.017. PMID 25174783.
1 2 3 4  “New 11 beta-aryl-substituted steroids exhibit both progestational and antiprogestational activity”. Steroids 63 (10):  523–30. (Oct 1998). doi:10.1016/S0039-128X(98)00060-9. PMID 9800283.
1 2  “16 alpha-substituted analogs of the antiprogestin RU486 induce a unique conformation in the human progesterone receptor resulting in mixed agonist activity”. Proceedings of the National Academy of Sciences of the United States of America 93 (16):  8739–44. (Aug 1996). Bibcode: 1996PNAS...93.8739W. doi:10.1073/pnas.93.16.8739. PMC 38743. PMID 8710941. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC38743/.
1 2 3 4  “Parallel synthesis and SAR study of novel oxa-steroids as potent and selective progesterone receptor antagonists”. Bioorganic & Medicinal Chemistry Letters 17 (9):  2531–4. (May 2007). doi:10.1016/j.bmcl.2007.02.013. PMID 17317167.
↑  “Synthesis and identification of novel oxa-steroids as progesterone receptor antagonists”. Bioorganic & Medicinal Chemistry Letters 17 (4):  907–10. (Feb 2007). doi:10.1016/j.bmcl.2006.11.062. PMID 17169557.
1 2  “11-(pyridinylphenyl)steroids--a new class of mixed-profile progesterone agonists/antagonists”. Bioorganic & Medicinal Chemistry 16 (6):  2753–63. (Mar 2008). doi:10.1016/j.bmc.2008.01.010. PMID 18243712.
↑  “Synthesis and SAR study of novel pseudo-steroids as potent and selective progesterone receptor antagonists”. Bioorganic & Medicinal Chemistry Letters 19 (14):  3977–80. (Jul 2009). doi:10.1016/j.bmcl.2009.01.095. PMID 19217285.
↑  “Insight from molecular modeling into different conformation and SAR of natural steroids and unnatural 7-oxa-steroids”. Bioorganic & Medicinal Chemistry Letters 18 (13):  3687–90. (Jul 2008). doi:10.1016/j.bmcl.2008.05.070. PMID 18539027.
↑  “Suspension of ulipristal acetate for uterine fibroids during ongoing EMA review of liver injury risk”.   EMA. 2021年11月11日閲覧。
1 2  “Selective progesterone receptor modulators: an update”. Expert Opinion on Pharmacotherapy 15 (10):  1403–15. (Jul 2014). doi:10.1517/14656566.2014.914494. PMID 24787486.
↑  “Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture”. Human Reproduction 25 (9):  2256–63. (Sep 2010). doi:10.1093/humrep/deq157. PMID 20634186.
↑  “Recent advances in contraception”. F1000Prime Reports 6:  113. (2014). doi:10.12703/p6-113. PMC 4251416. PMID 25580267. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251416/.
1 2  “Asoprisnil (J867): a selective progesterone receptor modulator for gynecological therapy”. Steroids 68 (10–13):  1019–32. (Nov 2003). doi:10.1016/j.steroids.2003.09.008. PMID 14667995.
↑  “Progesterone antagonists and progesterone receptor modulators: an overview”. Steroids 68 (10–13):  981–93. (Nov 2003). doi:10.1016/j.steroids.2003.08.007. PMID 14667991.
↑  “Emerging therapy for endometriosis”. Expert Opinion on Emerging Drugs 20 (3):  449–61. (Sep 2015). doi:10.1517/14728214.2015.1051966. PMID 26050551.
↑  “A Phase 2, Study to Evaluate the Safety and Efficacy Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Uterine Fibroids - Full Text View - ClinicalTrials.gov”. clinicaltrials.gov. 2016年1月11日閲覧。
↑  “Proellex”. ClinicalTrials.gov.   U.S. National Institutes of Health. 1 April 2021閲覧。
↑  “Systemic therapy of Cushing's syndrome”. Orphanet Journal of Rare Diseases 9 (1):  122. (Aug 2014). doi:10.1186/s13023-014-0122-8. PMC 4237936. PMID 25091295. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237936/.
↑  “Recent scientific advances in leiomyoma (uterine fibroids) research facilitates better understanding and management”. F1000Research 4 (F1000 Faculty Rev):  183. (2015). doi:10.12688/f1000research.6189.1. PMC 4513689. PMID 26236472. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513689/.
↑  “Telapristone acetate Withdrawn Phase 2 Trials for Endometriosis Treatment”.   drugbank. 2021年11月11日閲覧。
↑  “Colon cancer and the epidermal growth factor receptor: Current treatment paradigms, the importance of diet, and the role of chemoprevention”. World Journal of Clinical Oncology 6 (5):  133–41. (Oct 2015). doi:10.5306/wjco.v6.i5.133. PMC 4600187. PMID 26468449. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600187/.
↑  “Clinical utility of progesterone receptor modulators and their effect on the endometrium”. Current Opinion in Obstetrics and Gynecology 21 (4):  318–24. (Aug 2009). doi:10.1097/GCO.0b013e32832e07e8. PMID 19602929.
↑  “Organisation of the entire rabbit progesterone receptor mRNA and of the promoter and 5' flanking region of the gene”. Nucleic Acids Research 16 (12):  5459–72. (Jun 1988). doi:10.1093/nar/16.12.5459. PMC 336778. PMID 3387238. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC336778/.
↑  “The isolation of crystalline progestin”. Science 82 (2118):  89–93. (Aug 1935). Bibcode: 1935Sci....82...89A. doi:10.1126/science.82.2118.89. PMID 17747122.
↑  Karrer, P.; Schwarzenbach, G. (Jan 1934). “Nachtrag betreffend Acidität und Reduktions-Vermögen der Ascorbinsäure”. Helvetica Chimica Acta 17 (1):  58–59. doi:10.1002/hlca.19340170111. ISSN 1522-2675.
↑  “Progesterone-binding components of chick oviduct. I. Preliminary characterization of cytoplasmic components”. The Journal of Biological Chemistry 245 (22):  6085–96. (Nov 1970). doi:10.1016/S0021-9258(18)62667-5. PMID 5484467.
↑  Philibert D, Deraedt R, Deutsch G (1981). RU 38486: a potent antiglucocorticoid in vivo. The VII International Congress of Pharmacology. Japan: Tokyo.
1 2  “Chick oviduct glucocorticosteroid receptor. Specific binding of the synthetic steroid RU 486 and immunological studies with antibodies to chick oviduct progesterone receptor”. European Journal of Biochemistry 149 (2):  445–51. (Jun 1985). doi:10.1111/j.1432-1033.1985.tb08945.x. PMID 3996417.
↑  “The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation”. Endocrinology 139 (4):  1905–19. (Apr 1998). doi:10.1210/endo.139.4.5944. PMID 9528977.
↑  “The influence of antiglucocorticoids on stress and shock”. Annals of the New York Academy of Sciences 761 (1):  276–95. (Jun 1995). Bibcode: 1995NYASA.761..276L. doi:10.1111/j.1749-6632.1995.tb31384.x. PMID 7625726.
↑  “Progesterone receptor modulators and progesterone antagonists in women's health”. Steroids 65 (10–11):  807–15. (Aug 2010). doi:10.1016/S0039-128X(00)00194-X. PMID 11108892.
↑  “A novel selective progesterone receptor modulator asoprisnil (J867) inhibits proliferation and induces apoptosis in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells”. The Journal of Clinical Endocrinology and Metabolism 91 (4):  1296–304. (Apr 2006). doi:10.1210/jc.2005-2379. PMID 16464945.
↑  “Endocrine pharmacological characterization of progesterone antagonists and progesterone receptor modulators with respect to PR-agonistic and antagonistic activity”. Steroids 65 (10–11):  713–23. (2000-10-01). doi:10.1016/S0039-128X(00)00178-1. PMID 11108882.
↑  “Nonsteroidal progesterone receptor ligands with unprecedented receptor selectivity”. The Journal of Steroid Biochemistry and Molecular Biology 75 (1):  33–42. (Dec 2000). doi:10.1016/S0960-0760(00)00134-5. PMID 11179906.
↑  “Safety of Treatment of Uterine Fibroids With Asoprisnil - Full Text View - ClinicalTrials.gov”. clinicaltrials.gov. 2016年1月11日閲覧。
↑  “Long-term treatment of uterine fibroids with ulipristal acetate”. Fertility and Sterility 101 (6):  1565–73.e1–18. (Jun 2014). doi:10.1016/j.fertnstert.2014.02.008. PMID 24630081.
↑  “Assessment Report for Ellaone”.   EMA. Nov 2009閲覧。
↑  “Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety”. Fertility and Sterility 96 (5):  1175–89. (Nov 2011). doi:10.1016/j.fertnstert.2011.08.021. PMID 21944187.
プロゲステロン受容体の立体構造
プロゲステロン骨格の番号
SPRMの作用機序：この図では、SPRMをホルモン、プロゲステロンの受容体をNR（核内受容体）としている。
ミフェプリストン類縁体の構造活性相関
左上：作動薬／遮断薬活性の強度
右上：PR／GR選択性
下：O置換によるPR選択性向上
（PR：プロゲステロン受容体）
（GR：糖質コルチコイド受容体）